Our previous studies have found that defective RTK signaling transduction is not only limited to VEGF/VEGFR, but is also associated with the disruption of Ang-1/Tie-2 angiogenic signaling and angiogenesis under hyperglycemic conditions and in diabetes [9–11]. The gene discussed is TEK; the disease is diabetes mellitus.